Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atricure Inc
(NQ:
ATRC
)
23.87
-0.04 (-0.17%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Atricure Inc
< Previous
1
2
3
4
5
Next >
AtriCure to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
August 16, 2022
From
AtriCure, Inc.
Via
Business Wire
5 Analysts Have This to Say About AtriCure
August 03, 2022
Within the last quarter, AtriCure (NASDAQ:ATRC) has observed the following analyst ratings:
Via
Benzinga
AtriCure: Q2 Earnings Insights
August 02, 2022
AtriCure (NASDAQ:ATRC) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings AtriCure missed estimated earnings by...
Via
Benzinga
AtriCure Reports Second Quarter 2022 Financial Results
August 02, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Participate at Upcoming Investor Conferences
July 20, 2022
From
AtriCure, Inc.
Via
Business Wire
5 Analysts Have This to Say About AtriCure
July 18, 2022
Over the past 3 months, 5 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
AtriCure to Announce Second Quarter 2022 Financial Results
July 12, 2022
From
AtriCure, Inc.
Via
Business Wire
Analyst Ratings for AtriCure
June 28, 2022
Over the past 3 months, 4 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
AtriCure Announces the First Patient Treated in the HEAL-IST Clinical Trial
June 07, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure Announces the Appointment of Deborah Yount as Chief Human Resources Officer
June 01, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure's Q1 EPS Miss Estimates, Needham Lowers Price Target
May 04, 2022
Needham lowered AtriCure Inc's (NASDAQ: ATRC) price target to $67 from $79 due to peer multiple compression, with the Buy rating unchanged.
Via
Benzinga
4 Analysts Have This to Say About AtriCure
May 04, 2022
Over the past 3 months, 4 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
AtriCure: Q1 Earnings Insights
May 03, 2022
AtriCure (NASDAQ:ATRC) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings AtriCure missed estimated earnings by...
Via
Benzinga
AtriCure Reports First Quarter 2022 Financial Results
May 03, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure Launches EnCompass® Clamp, a part of Isolator Synergy™ Ablation System
April 12, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Announce First Quarter 2022 Financial Results
April 11, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure Reports Deeper Losses In Q4 Despite 27% Jump In Sales, Issues FY22 Guidance
February 16, 2022
AtriCure Inc (NASDAQ: ATRC) reported Q4
Via
Benzinga
Recap: AtriCure Q4 Earnings
February 15, 2022
AtriCure (NASDAQ:ATRC) reported its Q4 earnings results on Tuesday, February 15, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings AtriCure missed estimated earnings...
Via
Benzinga
AtriCure Reports Fourth Quarter 2021 and Full Year 2021 Financial Results
February 15, 2022
From
AtriCure, Inc.
Via
Business Wire
The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics
February 15, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus ImmunityBio Says Cancer Combo Therapy Produces Positive Results In Late-Stage...
Via
Benzinga
A Preview Of AtriCure's Earnings
February 14, 2022
AtriCure (NASDAQ:ATRC) is set to give its latest quarterly earnings report on Tuesday, 2022-02-15. Here's what investors need to know before the announcement. Analysts estimate that AtriCure will...
Via
Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
February 13, 2022
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news...
Via
Benzinga
Earnings Scheduled For February 15, 2022
February 15, 2022
Companies Reporting Before The Bell • FirstService (NASDAQ:FSV) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.07 billion.
Via
Benzinga
AtriCure Publishes Inaugural ESG Report
February 08, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
February 01, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Announce Fourth Quarter and Full Year 2021 Financial Results
January 25, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2021, Provides Financial Outlook for 2022
January 10, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Participate in the 40th Annual J.P. Morgan Healthcare Conference
December 20, 2021
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference
November 12, 2021
From
AtriCure, Inc.
Via
Business Wire
AtriCure, inc (ATRC) Q3 2021 Earnings Call Transcript
November 04, 2021
ATRC earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.